2-Aryl Triazole Synthesis for Selective Orexin Modulator Manufacturing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing synthesis methods for (((3aR,6aS)-5-(4,6-dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanone) suffer from low yield, waste generation, and the need for separating undesired coupling products, leading to high manufacturing costs.

Innovation Solution

A process involving a single-step cyclization of hydrazone to form 2-phenyl-2H-1,2,3-triazole, followed by carboxylation and reaction with (3aR,6aS)-2-(4,6-dimethylpyrimidin-2-yl)octahydropyrrolo[3,4-c]pyrrole, using specific reagents to minimize by-products and improve yield.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If direct phenyl-to-triazole coupling is employed, then the synthesis can be completed in a single step, but unselective coupling to different nitrogen atoms produces multiple products requiring separation

Engineering Contradiction:
Improvesynthesis speedVSAvoidproduct selectivity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent introduces a copper catalyst as an intermediary to mediate the coupling reaction between phenyl and triazole. This catalyst enables selective formation of the desired product by facilitating coupling at a specific nitrogen atom, thereby resolving the selectivity issue while maintaining the efficiency of a single-step synthesis approach

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If Cu(II) mediated bis-hydrazone cyclization is used to achieve exclusive 2-aryltriazole synthesis, then product selectivity is improved, but atom economy deteriorates due to 50% conversion of aryl building block to aniline by-product

Engineering Contradiction:
Improveproduct selectivityVSAvoidatom economy
Core Design Contradiction:
Manufacturing precisionVSLoss of substance

Solution Approach 1:

The patent extracts or removes the problematic bis-addition pathway that generates aniline by-products. By using a modified copper-mediated cyclization approach with controlled stoichiometry and conditions, the method selectively forms the desired triazole product while preventing the formation of unwanted by-products, thereby improving atom economy while maintaining selectivity

Inventive Principle:
Principle #2Taking out (Extraction)

3Manufacturing precision

If traditional multi-step synthesis with separation is employed, then product purity can be achieved, but manufacturing cost increases due to additional separation steps

Engineering Contradiction:
Improveproduct purityVSAvoidmanufacturing cost
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent converts the potential harm of unselective coupling into a benefit by using copper-mediated cyclization conditions that transform the mixture of possible products into a single dominant product. The reaction conditions are designed so that even if multiple coupling sites are initially accessible, the copper catalyst and reaction parameters guide the system to preferentially form the desired triazole product, eliminating the need for costly separation steps while maintaining high purity

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method reduces waste, lowers manufacturing costs, and enhances the yield of the target compound by eliminating the need for separating undesired products, thereby optimizing the synthesis process.

Implementation Method 1

cyclization of the hydrazone of Formula I to give the 2-phenyl-2H-1,2,3-triazole of Formula II

Methodology Applied
Scientific EffectCyclization:

Data Source

PatentUS12570658B2Synthetic methods of making (2H-1, 2, 3-triazol-2-yl) phenyl compounds as orexin receptor modulators
Publication Date: 2026.03.10 JANSSEN PHARMA NV
  • US12570658B2 patent drawing
  • US12570658B2 patent drawing
  • US12570658B2 patent drawing

AI summary

Processes for preparing (((3aR,6aS)-5-(4,6-dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanoneare described, which are useful for commercial manufacturing. Said compound is an orexin receptor modulator and may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia and depression.